Oncura Inc

ONCURA, an Amersham business, was created through the merger of Amersham's (LSE, NYSE, OSE: AHM) brachytherapy business with Galil Medical Ltd's urology business. Headquartered in the United States, ONCURA operates as an independent business of Amersham plc, with Galil holding a minority position of 25 percent. ONCURA has a major global presence in the treatment of prostate cancer, combining the market leadership of Amersham in brachytherapy with the rapidly growing area of cryotherapy. ( www.oncura.com )